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Background
miRNAs are short 21-24 nt RNAs that mediate post tran-
scriptional repression of target genes. Various reports have
shown that miRNAs are capable of repressing the gene
expression levels of different viruses, leading to the sug-
gestion that miRNAs are key mediators of host-virus inter-
action [1]. HIV-1 is a retrovirus known to cause AIDS, one
of the major diseases in humans. The nef gene of the HIV-
1 has been shown to be important for virus repression of
CD4+ cells and virus progression. It has also been shown
earlier that patients infected with nef deleted HIV-1 do not
progress from infected to diseased state for longer periods
of time, resulting in the Long Term Non-Progressor phe-
notype [2].
Materials and methods
We computationally predicted five endogenously
expressed human miRNAs to target the nef gene of HIV-1
retrovirus. On applying other stringency parameters we
could focus on two of the five miRNAs viz. hsa-mir-29a
and hsa-mir-29b as they were predicted to target the nef
gene, at sites highly conserved amongst other clades of
HIV-1 [3].
We then created reporter carrying the nef gene inserted
downstream of a luciferase reporter. miRNA expression
vectors were also made which would express the pri-
miRNA when processed and thereby lead to high levels of
the miRNA inside the cells. We then identified various cell
lines for validating nef as a target for hsa-mir-29a and hsa-
mir-29b.
Results and discussion
Gene reporter assays and ectopic over-expression of miR-
NAs conclusively showed that human cellular miRNAs
hsa-mir-29a and hsa-mir-29b could bring down the nef
protein levels and also affect viral replication [4]. These
results would provide a better understanding of the mech-
anisms that could regulate the viral gene expression and
human cellular antiviral defense mechanisms whereby
miRNAs could serve as potential therapeutics to treat var-
ious viral diseases.
References
1. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK: Host-virus
interaction: a new role for microRNAs.  Retrovirology 2006, 3:68.
2. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M,
Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al.:
Genomic structure of an attenuated quasi species of HIV-1
from a blood transfusion donor and recipients.  Science 1995,
270:988-991.
3. Hariharan M, Scaria V, Pillai B, Brahmachari SK: Targets for human
encoded microRNAs in HIV genes.  Biochem Biophys Res Commun
2005, 337:1214-1218.
4. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria
V, Lalwani M, Pillai B, Mitra D, Brahmachari SK: Human cellular
microRNA hsa-miR-29a interferes with viral nef protein
expression and HIV-1 replication.  Retrovirology 2008, 5:117.
from Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Montpellier, France. 21-23 September 2009
Published: 24 September 2009
Retrovirology 2009, 6(Suppl 2):P83 doi:10.1186/1742-4690-6-S2-P83
<supplement> <title> <p>Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S2-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-6-S2-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S2/P83
© 2009 Soni et al; licensee BioMed Central Ltd. 
